Evidence map›Paper›PMID 30634050›Full record

ArticlePharmacological research2019

Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G

Matthew M Meleka, Alethia J Edwards, Jingsheng Xia, Shelby A Dahlen, Ipsita Mohanty, Matthew Medcalf, Shaili Aggarwal, Kevin D Moeller, Ole V Mortensen, Patrick Osei-Owusu

Abstract read
In one paragraph

Article in Pharmacological research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Stabilization of interdomain closure by a G protein inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. The Bacterial GJournal of chemical ecology · 2023
    Article
  5. Article
  6. Exploring pharmacological inhibition of GBritish journal of pharmacology · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Matthew M MelekaDepartments of Pharmacology & Physiology, United States; Internal Medicine, Drexel University College of Medicine, Philadelphia, PA, 19102, United States.
Alethia J EdwardsDepartments of Pharmacology & Physiology, United States.
Jingsheng XiaDepartments of Pharmacology & Physiology, United States.
Shelby A DahlenDepartments of Pharmacology & Physiology, United States.
Ipsita MohantyDepartments of Pharmacology & Physiology, United States.
Matthew MedcalfDepartment of Chemistry, Washington University, St. Louis, MO, 63130, United States.
Shaili AggarwalDepartments of Pharmacology & Physiology, United States.
Kevin D MoellerDepartment of Chemistry, Washington University, St. Louis, MO, 63130, United States.
Ole V MortensenDepartments of Pharmacology & Physiology, United States.
Patrick Osei-OwusuDepartments of Pharmacology & Physiology, United States. Electronic address: po66@drexel.edu.
Brain Physiology Lab · FRDrexel University · USWashington University in St. Louis · US

Funding

PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASER01GM124093 · NIGMS · WASHINGTON UNIVERSITY · PI BLUMER, KENDALL J, MOELLER, KEVIN DAVID · 2017 to 2024
$3.6M
Computational and functional studies of allosteric monoamine transporter modulationR01MH106912 · NIMH · DREXEL UNIVERSITY · PI KORTAGERE, SANDHYA, MORTENSEN, OLE VALENTE · 2015 to 2019
$2.0M
In Vivo Mechanisms of Integrated G protein Signaling Regulation by RGS ProteinsR01HL139754 · NHLBI · DREXEL UNIVERSITY · PI OSEI-OWUSU, PATRICK · 2018 to 2021
$1.6M
NEW METHODS FOR THE SYNTHESIS AND ANALYSIS OF ADDRESSABLE MOLECULAR LIBRARIESR01GM122747 · NIGMS · WASHINGTON UNIVERSITY · PI MOELLER, KEVIN DAVID · 2018 to 2021
$1.1M
NHLBI NIH HHS R01 HL139754NIGMS NIH HHS R01 GM122747NIGMS NIH HHS R01 GM124093NIMH NIH HHS R01 MH106912
6 · The paper itself

Abstract

Augmented vasoconstriction is a hallmark of hypertension and is mediated partly by hyper-stimulation of G protein couple receptors (GPCRs) and downstream signaling components. Although GPCR blockade is a key component of current anti-hypertensive strategies, whether hypertension is better managed by directly targeting G proteins has not been thoroughly investigated. Here, we tested whether inhibiting G

Indexed as

AnimalsAntihypertensive AgentsArdisiaChromobacteriumDepsipeptidesFemaleGTP-Binding Protein alpha Subunits, Gq-G11HypertensionLigandsMaleMiceMice, Inbred C57BLPeptides, CyclicVasoconstrictionAntihypertensive AgentsDepsipeptidesFR900359GTP-Binding Protein alpha Subunits, Gq-G11LigandsPeptides, CyclicYM-254890Arginine vasopressin (CID: 644077)Bay K8644 (CID: 2303Blood pressureCalcium signalingCyclic depsipeptidesEndothelin-1 (CID: 16212950)FR900359 (CID: 14101198)G proteinsG(q/11) inhibitor ligandsL-type calcium channelNifedipine (CID: 63011)Phenylephrine (CID: 5284443)U46619 (CID: 5311493)WU-07047 (PMID: 25875152)YM-254890 (CID: 9919454)

Identifiers

PMID30634050
PMCPMC6417918
OpenAlexW2909143704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.